Appropriate chemotherapy for palliating advanced cancer.
作者信息
Rubens R D, Towlson K E, Ramirez A J, Coltart S, Slevin M L, Terrell C, Timothy A R
机构信息
Imperial Cancer Research Fund, Clinical Oncology Unit, Guy's Hospital, London.
出版信息
BMJ. 1992 Jan 4;304(6818):35-40. doi: 10.1136/bmj.304.6818.35.
Abstract
摘要
相似文献
1
Appropriate chemotherapy for palliating advanced cancer.
BMJ. 1992 Jan 4;304(6818):35-40. doi: 10.1136/bmj.304.6818.35.
2
Investigational and practical chemotherapy of solid tumors.实体瘤的研究性与实用性化疗
Geriatrics. 1970 Oct;25(10):113-25.
3
Chemotherapy of solid tumours.
World Health Organ Tech Rep Ser. 1977(605):1-106.
4
"Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
Semin Oncol. 1977 Jun;4(2):203-16.
5
Amsacrine (AMSA)--a clinical review.安吖啶（AMSA）——临床综述。
J Clin Oncol. 1985 Apr;3(4):562-92. doi: 10.1200/JCO.1985.3.4.562.
6
Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.癌症化疗：其在血液系统恶性肿瘤和实体瘤治疗策略中的作用。
Recent Results Cancer Res. 1976(53):1-552.
7
[Treatment of 37 surgical cancers with associated or isolated chemotherapy].[37例伴有或孤立性化疗的外科癌症的治疗]
Bull Mem Soc Chir Paris. 1971;61(6):352-68.
8
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.晚期实体瘤患者接受化疗时的姑息性预后评分与生存情况
Support Care Cancer. 2008 Apr;16(4):359-70. doi: 10.1007/s00520-007-0302-3. Epub 2007 Jul 13.
9
[Chemotherapy of tumors with continuous intravenous infusion of cytostatics].[通过持续静脉输注细胞抑制剂进行肿瘤化疗]
Tumori. 1967 May-Jun;53(3):183-97. doi: 10.1177/030089166705300301.
10
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy.每两周注射一次的达贝泊汀α可缓解接受化疗的癌症患者的贫血症状。
Oncology (Williston Park). 2002 Oct;16(10 Suppl 11):23-9.
引用本文的文献
1
Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?晚期乳腺癌的化疗：哪些因素会影响肿瘤学家的决策？
Br J Cancer. 2001 May 4;84(9):1172-8. doi: 10.1054/bjoc.2001.1733.
2
Key issues in the treatment of advanced breast cancer. Expectations and outcomes.晚期乳腺癌治疗中的关键问题。期望与结果。
Pharmacoeconomics. 1996;9 Suppl 2:1-7. doi: 10.2165/00019053-199600092-00003.
3
Do patients with advanced breast cancer benefit from chemotherapy?晚期乳腺癌患者能从化疗中获益吗？
Br J Cancer. 1998 Dec;78(11):1488-94. doi: 10.1038/bjc.1998.711.
4
[Terminal care medicine--basic principles and perspectives].[临终关怀医学——基本原则与展望]
Med Klin (Munich). 1997 Feb 15;92(2):106-11. doi: 10.1007/BF03042292.
5
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland.
Support Care Cancer. 1996 May;4(3):180-5. doi: 10.1007/BF01682337.
6
Hospice management of patients receiving cytotoxic chemotherapy: problems and opportunities.接受细胞毒性化疗患者的临终关怀管理：问题与机遇
Br J Cancer. 1993 Dec;68(6):1205-9. doi: 10.1038/bjc.1993.505.
7
Appropriate chemotherapy for palliating advanced cancer.
BMJ. 1992 Feb 1;304(6822):318. doi: 10.1136/bmj.304.6822.318-c.
8
Appropriate chemotherapy for palliating advanced cancer.用于缓解晚期癌症的适当化疗。
BMJ. 1992 Feb 1;304(6822):318. doi: 10.1136/bmj.304.6822.318-b.
本文引用的文献
1
BACUP--the first two years: evaluation of a national cancer information service.英国癌症联合协会——头两年：一项全国癌症信息服务的评估
BMJ. 1988 Sep 10;297(6649):669-72. doi: 10.1136/bmj.297.6649.669.
2
Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials.卵巢癌化疗II期研究中患者的反应：对患者治疗及II期试验设计的启示
Br J Cancer. 1989 Apr;59(4):650-3. doi: 10.1038/bjc.1989.132.
3
Auditing palliative cancer chemotherapy.姑息性癌症化疗审计
Eur J Cancer. 1990;26(10):1023-5. doi: 10.1016/0277-5379(90)90041-q.
Zotero 插件